Soleus Capital Management »

Ascendis Pharma A S shares owned by Soleus Capital Management

Quarter-by-quarter ownership of Ascendis Pharma A S (ASND) shares owned by Soleus Capital Management from 13F filings

Historical chart of Soleus Capital Management investment in Ascendis Pharma A S

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma A S held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma A S by Soleus Capital Management

Quarter filed Position value Share count Share price at filing
2025-06-30 $15M 85k 172.60
2025-03-31 $8.8M 56k 155.86
2024-12-31 $20M 144k 137.67

More positions owned by Soleus Capital Management

Krystal Biotech (KRYS)
Tg Therapeutics (TGTX)
Novocure Ord Shs (NVCR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Anthem (ELV)
Beta Bionics (BBNX)
United Therapeutics Corporation (UTHR)
Terns Pharmaceuticals (TERN)
Celcuity (CELC)
Inspire Med Sys (INSP)
Twist Bioscience Corp (TWST)
Argenx Se Sponsored Adr (ARGX)
Organogenesis Hldgs (ORGO)
BioMarin Pharmaceutical (BMRN)
Cidara Therapeutics Com New (CDTX)

View all positions for Soleus Capital Management

Top funds holding Ascendis Pharma A S

RA Capital Management
Westfield Capital Management Company
venBio Select Advisor
FMR
Henderson Group
Lombard Odier Asset Management
Artisan Partners Limited Partnership
Capital Research and Management Company - Division 3
T. Rowe Price Investment Management
Massachusetts Financial Services
Wellington Management Company
Franklin Resources
Perceptive Advisors
Invesco
Polar Capital Holdings

View all funds holding Ascendis Pharma A S